论文信息 - Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience - 字舞流文

Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience

M. D. de Propris | D. Diverio | W. Barberi | A. Iori | U. La Rocca | S. Trisolini | M. Brescini | A. Bruzzese | L. Quattrocchi | G. Assanto | D. Carmini | Giulia Galassi